Stock Fundamentals

Company Information

Company Name
Relmada Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US75955J4022
CIK: 0001553643
CUSIP: 75955J402
Currency: USD
Full Time Employees: 17
Phone: 786 629 1376
Fiscal Year End: December
IPO Date: Oct 09, 2014
Description:

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. The company has an agreement with Asarina Pharma AB and Trigone. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.

Address:

2222 Ponce de Leon Blvd., Coral Gables, FL, United States, 33134

Directors & Officers

Name Title Year Born
Dr. Sergio Traversa M.B.A., Pharm.D. CEO & Director 1960
Mr. Maged S. Shenouda M.B.A., R.Ph. Chief Financial Officer 1964
Mr. Paul E. Kelly M.B.A. COO & Director 1957
Mr. Charles S. Ence CPA, M.B.A. Chief Accounting & Compliance Officer 1965
Ms. Gina DiGuglielmo VP & Head of Clinical Operations NA
Dr. Raj S. Pruthi F.A.C.S., M.D., M.H.A. Chief Medical Officer of Urology 1967
Dr. Andrew Cutler Senior Clinical Development Advisor NA
Dr. Richard M. Mangano Ph.D. Consultant 1950

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 15, 2025 Maged Shenouda N/A Purchase 11.67K $4.12 $48.06K
Nov 05, 2025 Chuck Ence N/A Purchase 136.00K $2.20 $299.20K
Nov 05, 2025 Maged Shenouda N/A Purchase 500.00K $2.20 $1.10M
Nov 05, 2025 Paul Edward Kelly N/A Purchase 90.00K $2.20 $198.00K
May 20, 2025 Maged Shenouda N/A Purchase 60.00K $0.52 $31.20K
May 19, 2025 Maged Shenouda N/A Purchase 90.00K $0.49 $44.10K
May 16, 2025 Chuck Ence N/A Purchase 228.96K $0.45 $103.03K
May 16, 2025 Maged Shenouda N/A Purchase 50.00K $0.44 $22.00K
May 16, 2025 Paul Edward Kelly N/A Purchase 200.00K $0.43 $86.00K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
HHG PLC 11.06M Mar 31, 2026 10.55% $0.04 52.19%
Squadron Capital Management LLC 8.47M Mar 31, 2026 8.08% $21.61 26.49%
Spruce Street Capital LP 6.26M Mar 31, 2026 5.97% $10.34 53.25%
VR Adviser, LLC 4.84M Mar 31, 2026 4.62% $1.26 0.00%
Adage Capital Partners Gp LLC 4.76M Mar 31, 2026 4.54% $0.05 11.55%
Orbimed Advisors, LLC 4.72M Mar 31, 2026 4.50% $0.65 80.64%
Marshall Wace Asset Management Ltd 4.48M Mar 31, 2026 4.27% $0.03 40.50%
Millennium Management LLC 3.91M Mar 31, 2026 3.73% $0.01 133.55%
Vanguard Capital Management, LLC 3.08M Mar 31, 2026 2.93% $0.00 0.00%
RA Capital Management, LLC 2.95M Mar 31, 2026 2.81% $0.22 0.00%
Ikarian Capital, LLC 2.69M Mar 31, 2026 2.56% $1.52 -12.38%
Driehaus Capital Management LLC 2.13M Mar 31, 2026 2.03% $0.11 13.41%
CI Private Wealth LLC 1.44M Dec 31, 2025 1.37% $0.00 596.37%
Polar Capital Holdings PLC 1.41M Mar 31, 2026 1.35% $0.04 0.00%
BlackRock Inc 1.29M Mar 31, 2026 1.23% $0.00 1.74%
Vanguard Group Inc 1.20M Dec 31, 2025 1.15% $0.00 187.47%
StemPoint Capital LP 1.19M Mar 31, 2026 1.14% $0.80 0.00%
Susquehanna International Group, LLP 1.01M Mar 31, 2026 0.96% $0.00 162.10%
Sio Capital Management, LLC 965.00K Mar 31, 2026 0.92% $0.96 0.00%
Opaleye Management Inc 935.00K Mar 31, 2026 0.89% $0.86 0.00%

Shares Statistics

Shares Outstanding: 104.99M
Shares Float: 7.72M
% Insiders: 290.30%
% Institutions: 8,965.80%
Short % Float: 10.78%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 2.18M 2.08% ▲ 0.00% Apr 30, 2026
2 Polar Capital Biotech S Inc 1.34M 1.28% ▲ 0.00% Apr 30, 2026
3 Biotech Growth Ord 1.31M 1.25% ▲ 0.00% Feb 28, 2026
4 Eventide Healthcare & Life Sciences I 842.11K 0.80% ▲ 0.00% Mar 31, 2026
5 Vanguard Institutional Extnd Mkt Idx Tr 829.41K 0.79% ▲ 0.48% Apr 30, 2026
6 AdvisorShares Psychedelics ETF 397.95K 0.38% ▲ 0.00% May 29, 2026
7 Fidelity Extended Market Index 386.37K 0.37% ▲ 1.93% Apr 30, 2026
8 IMC US Small Cap 238.26K 0.23% ▲ 0.00% Apr 30, 2026
9 Extended Equity Market Fund E 192.46K 0.18% ▲ 248.60% Dec 31, 2025
10 Extended Equity Market Fund B 192.46K 0.18% ▲ 248.60% Dec 31, 2025

Valuation Metrics

Enterprise Value: $-43.29M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $672.97M
EBITDA: $-13.86M
Book Value: $10.15
Earnings/Share: $-1.09
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -14.39%
ROE (TTM): -25.63%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 14.62x 0.00x 0.08x N/A 0.00x
2024-12-31 4.45x 0.00x 0.22x N/A 0.00x
2023-12-31 8.00x 0.00x 0.13x N/A 0.00x
2022-12-31 12.26x 0.00x 0.08x -38.34x 0.00x
2021-12-31 14.83x 0.00x 0.07x -2,601.64x 0.00x
2020-12-31 9.37x 0.00x 0.11x -43.48x 0.00x
2019-12-31 80.21x 0.00x 0.01x N/A -0.01x
2018-12-31 0.46x -0.05x 2.81x -5.17x -0.04x
2017-12-31 1.80x 2.01x 0.49x -13,125.45x -0.42x
2016-12-31 3.04x 0.04x 0.31x N/A -0.02x
2015-12-31 1.54x 0.03x 0.64x -3,473.99x -0.02x
2014-12-31 1.54x 0.03x 0.64x -3,474.05x -0.01x
2014-06-30 0.96x -0.05x 1.04x N/A N/A
2013-12-31 0.96x 0.00x 1.04x N/A -1.30x
2012-12-31 2.62x 0.00x 0.38x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about RLMD.US!